Source: Global Legal Chronicle

Guide: Beam Therapeutics' $120 Million Acquisition of GuideTx

Orrick Herrington & Sutcliffe LLP advised Guide Therapeutics on the deal. Guide Therapeutics (GuideTx), a developer of nonviral drug delivery vehicles for genetic medicines, announced its acquisition [...]

Read full article »

Guide's Competitors | Guide's News | Guide's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

1-25

Co-Founder

Cory Sago

CEO Approval Rating

90/100

Guide Therapeutics is a Georgia-based biopharmaceutical company that develops and commercializes gene therapies for the treatment of serious diseases.